Foxo Technologies Inc
OTC:FOXO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Foxo Technologies Inc
Total Other Income
Foxo Technologies Inc
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Foxo Technologies Inc
OTC:FOXO
|
Total Other Income
-$320.4k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Salesforce Inc
NYSE:CRM
|
Total Other Income
$172m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
28%
|
|
|
Palantir Technologies Inc
NASDAQ:PLTR
|
Total Other Income
$14.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Applovin Corp
NASDAQ:APP
|
Total Other Income
$8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Intuit Inc
NASDAQ:INTU
|
Total Other Income
$103m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Adobe Inc
NASDAQ:ADBE
|
Total Other Income
$235m
|
CAGR 3-Years
41%
|
CAGR 5-Years
126%
|
CAGR 10-Years
27%
|
|
Foxo Technologies Inc
Glance View
FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota and currently employs 24 full-time employees. The company went IPO on 2020-12-11. The firm is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The firm operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.
See Also
What is Foxo Technologies Inc's Total Other Income?
Total Other Income
-320.4k
USD
Based on the financial report for Dec 31, 2024, Foxo Technologies Inc's Total Other Income amounts to -320.4k USD.
What is Foxo Technologies Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
-10%
Over the last year, the Total Other Income growth was 90%. The average annual Total Other Income growth rates for Foxo Technologies Inc have been -10% over the past three years .
